LIVE COMMAND CENTERPlatformRequest Access
Investor-Grade Neuro Intelligence

See the market before the market sees itself.

A decision terminal that converts neurodevelopmental demand, research intensity, trial activity and country readiness into market timing, expansion priorities and executive action.

ClarityRank the signal, remove the noise.
ControlAct with quantified confidence.
UrgencyMove before markets mature.

Neuro-Market Intelligence Layer

Research
Forecast
Markets
CLINICAL 12,998 Mapped clinical trials
EXECUTIVE 91.06% Average intelligence confidence
EXECUTIVE 84.50% Enterprise Readiness
FORECAST 2,030 Forecast horizon
GLOBAL 18 Countries monitored
MARKET 87.40% Global opportunity index
RESEARCH 125,710 Indexed neuroscience publications
EUROPE 78 Avg opportunity · Leader: Germany
APAC 77.80 Avg opportunity · Leader: Australia
LATAM 61.33 Avg opportunity · Leader: Brazil
NA 89 Avg opportunity · Leader: United States
AFRICA 53.50 Avg opportunity · Leader: South Africa

Global Opportunity Heatmap

Priority Markets

01United StatesUS · NA
92
02AustraliaAU · APAC
87
03CanadaCA · NA
86
04GermanyDE · EUROPE
85
05ChinaCN · APAC
84
06FranceFR · EUROPE
82
07JapanJP · APAC
81
08NetherlandsNL · EUROPE
81

Live Intelligence Feed

INFO dashboard_restore

Live dashboard rebuilt from PostgreSQL-backed KPIs

INFO database_restore

NeuroRisk executive database content restored

INFO openalex_ingest

Ingested 30 publications for epilepsy

INFO clinical_trials_ingest

Ingested 30 trials for epilepsy

INFO openalex_ingest

Ingested 30 publications for adhd

INFO clinical_trials_ingest

Ingested 30 trials for adhd

INFO openalex_ingest

Ingested 30 publications for autism

INFO clinical_trials_ingest

Ingested 30 trials for autism

INFO openalex_ingest

Ingested 30 publications for parkinson

INFO clinical_trials_ingest

Ingested 30 trials for parkinson

INFO openalex_ingest

Ingested 30 publications for alzheimer

INFO clinical_trials_ingest

Ingested 30 trials for alzheimer

Forecast 2026–2030

restored-neurorisk-forecast 2026 Neurodevelopmental Intelligence 100 Confidence 88%
restored-neurorisk-forecast 2027 Neurodevelopmental Intelligence 136 Confidence 88%
restored-neurorisk-forecast 2028 Neurodevelopmental Intelligence 182 Confidence 88%
restored-neurorisk-forecast 2029 Neurodevelopmental Intelligence 241 Confidence 88%
restored-neurorisk-forecast 2030 Neurodevelopmental Intelligence 318 Confidence 88%

Opportunity Bar Chart

United States: 92USAustralia: 87AUCanada: 86CAGermany: 85DEChina: 84CNFrance: 82FRJapan: 81JPNetherlands: 81NLUnited Kingdom: 80GBSouth Korea: 73KRItaly: 71ITSpain: 69ES

Research × Opportunity Matrix

Research intensityOpportunityUnited States · Research 50 · Opportunity 92Australia · Research 45 · Opportunity 87Canada · Research 55 · Opportunity 86Germany · Research 46 · Opportunity 85China · Research 72 · Opportunity 84France · Research 35 · Opportunity 82Japan · Research 33 · Opportunity 81Netherlands · Research 33 · Opportunity 81United Kingdom · Research 21 · Opportunity 80South Korea · Research 5 · Opportunity 73Italy · Research 31 · Opportunity 71Spain · Research 29 · Opportunity 69Brazil · Research 20 · Opportunity 65India · Research 25 · Opportunity 64Mexico · Research 24 · Opportunity 61Argentina · Research 22 · Opportunity 58South Africa · Research 18 · Opportunity 55Nigeria · Research 14 · Opportunity 52

Country Intelligence Table

RankCountryISORegionResearchTrialsOpportunityConfidenceRecommended Action
1 United States US NA 50 100 92 90% Scale now
2 Australia AU APAC 45 76 87 90% Scale now
3 Canada CA NA 55 82 86 90% Scale now
4 Germany DE EUROPE 46 80 85 90% Scale now
5 China CN APAC 72 90 84 90% Scale now
6 France FR EUROPE 35 72 82 90% Scale now
7 Japan JP APAC 33 58 81 90% Scale now
8 Netherlands NL EUROPE 33 68 81 90% Scale now
9 United Kingdom GB EUROPE 21 86 80 90% Scale now
10 South Korea KR APAC 5 54 73 90% Develop pipeline
11 Italy IT EUROPE 31 64 71 84% Develop pipeline
12 Spain ES EUROPE 29 60 69 84% Develop pipeline
13 Brazil BR LATAM 20 34 65 90% Develop pipeline
14 India IN APAC 25 30 64 90% Monitor
15 Mexico MX LATAM 24 24 61 80% Monitor
16 Argentina AR LATAM 22 22 58 78% Monitor
17 South Africa ZA AFRICA 18 18 55 76% Monitor
18 Nigeria NG AFRICA 14 12 52 74% Monitor

Executive Products

INTELLIGENCE PRODUCT Global Neuro Market Intelligence

Recovered executive intelligence layer with research, trials, forecast and opportunity scoring.

Confidence 94%
INTELLIGENCE PRODUCT Clinical Trials Intelligence

Operational clinical trial intelligence layer for global neurodevelopment and neuroscience monitoring.

Confidence 91%
INTELLIGENCE PRODUCT NeuroRisk Forecast 2030

Strategic forecast layer rebuilt for country, research and market readiness projections.

Confidence 89%

Decision Narrative

Where to expand first?

Start with markets above 80 opportunity and 80 confidence. They create the strongest commercial and institutional narrative.

Expansion priority
Where to build evidence?

Markets with opportunity above 60 but lower research signal should receive research partnerships and data enrichment.

Evidence strategy

Executive Framing

Clarity

Every visual leads to a ranked decision.

Low cognitive load
Control

Scores, confidence and forecasts make uncertainty manageable.

Command perception
Urgency

Forecast growth and live events signal market movement.

Action pressure
© NeuroRisk.ai — Global Neuro Intelligence InfrastructureTerminal V74 · Cards · Maps · Photos · Tables · Charts · Decision framing